RIO DE JANEIRO, BRAZIL - Brazil will begin its final testing stage for one of the proposed coronavirus vaccines on July 20th. Brazil's National Health Regulatory Agency (ANVISA) authorized the start of trials by the Butantan Institute in São Paulo, a partner of Chinese pharmaceutical company Sinovac Biotech since last month.
With 1.6 million cases and almost 65,000 deaths from the disease, Brazil has come under international companies' radar as a volunteer center for the trials, which require a location where the virus circulation is still high. In addition to joining the Chinese initiative, the country has . . .